Vpu and BST2: Still not there yet?

Frontiers in Microbiology

Volumn 3, Issue APR, 2012, Pages

  Sato, Kei ^a   Gee, Peter ^a   Koyanagi, Yoshio ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Bst2; Hiv 1; Pandemic; Restriction factor; Viral evolution; Vpu

Indexed keywords

EID: 84866106255     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2012.00131     Document Type: Article

References (101)

1. Abudu, A., Takaori-Kondo, A., Izumi, T., Shirakawa, K., Kobayashi, M., Sasada, A., Fukunaga, K., and Uchiyama, T. (2006). Murine retrovirus escapes from murine APOBEC3 via two distinct novel mechanisms. Curr. Biol. 16, 1565-1570.
2. Aldrovandi, G. M., and Zack, J. A. (1996). Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice. J. Virol. 70, 1505-1511.
3. Arias, J. F., Iwabu, Y., and Tokunaga, K. (2011). Structural basis for the antiviral activity of BST-2/Tetherin and its viral antag- onism. Front. Microbiol. 2:250. doi:10.3389/fmicb.2011.00250
4. Bailes, E., Gao, F., Bibollet-Ruche, F., Courgnaud, V., Peeters, M., Marx, P. A., Hahn, B. H., and Sharp, P. M. (2003). Hybrid origin of SIV in chimpanzees. Science 300,1713.
5. Barre-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vezinet-Brun, E, Rouzioux, C., Rozenbaum, W., and Montagnier, L. (1983). Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220, 868-871.
6. Belshaw, R., Pereira, V., Katzourakis, A., Talbot, G., Paces, J., Burt, A., and Tristem, M. (2004). Long-term reinfection of the human genome by endogenous retroviruses. Proc. Natl. Acad. Sci. U.S.A. 101,4894-4899.
7. Blasius, A. L., Giurisato, E., Cella, M., Schreiber, R. D., Shaw, A. S., and Colonna, M. (2006). Bone marrow stromal cell antigen 2 is a specific marker of type I IFN-pro ducing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation. J. Immunol. 177, 3260-3265.
8. Bour, S., Schubert, U., Peden, K., and Strebel, K. (1996). The envelope glycoprotein of human immunode- ficiency virus type 2 enhances viral particle release: a Vpu-like factor? J. Virol. 70, 820-829.
9. Bour, S., and Strebel, K. (1996). The human immunodeficiency virus (HIV) type 2 envelope protein is a functional complement to HIV type 1 Vpu that enhances particle release of heterologous retroviruses. J. Virol. 70,8285-8300.
10. Brown, D., Trowsdale, J., and Allen, R. (2004). The LILR family: modulators of innate and adaptive immune pathways in health and disease. Tissue Antigens 64, 215-225.
11. Cao, W., Bover, L., Cho, M., Wen, X., Hanabuchi, S., Bao, M., Rosen, D. B., Wang, Y. H., Shaw, J. L., Du, Q., Li, C., Arai, N., Yao, Z., Lanier, L. L., and Liu, Y. J. (2009). Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction. J. Exp. Med. 206, 1603-1614.
12. Casartelli, N., Sourisseau, M., Feldmann, J., Guivel-Benhassine, E, Mallet, A., Marcelin, A. G., Guatelli, J., and Schwartz, O. (2010). Tetherin restricts productive HIV-1 cell-to-cell transmission. PLoS Pathog. 6, e1000955. doi:10.1371/journal.ppat.1000955
13. Chen, E C., and Li, W. H. (2001). Genomic divergences between humans and other hominoids and the effective population size of the common ancestor of humans and chimpanzees. Am. J. Hum. Genet. 68,444-456.
14. Courgnaud, V., Abela, B., Pourrut, X., Mpoudi-Ngole, E., Loul, S., Delaporte, E., and Peeters, M. (2003). Identification of a new simian immunodeficiency virus lineage with a vpu gene present among different cercopithecus monkeys (C. mona, C. cephus, and C. nictitans) from Cameroon. J. Virol. 77, 12523-12534.
15. Courgnaud, V., Salemi, M., Pourrut, X., Mpoudi-Ngole, E., Abela, B., Auzel, P., Bibollet-Ruche, F., Hahn, B., Vandamme, A. M., Delaporte, E., and Peeters, M. (2002). Characterization of a novel simian immunodeficiency virus with a vpu gene from greater spot-nosed monkeys (Cercopithecus nictitans) provides new insights into simian/human immunodeficiency virus phylogeny. J. Virol. 76,8298-8309.
16. Dietrich, I., Mcmonagle, E. L., Petit, S. J., Vijayakrishnan, S., Logan, N., Chan, C. N., Towers, G. J., Hosie, M. J., and Willett, B. J. (2011). Feline tetherin efficiently restricts release of feline immunodeficiency virus but not spreading of infection. J. Virol. 85,5840-5852.
17. Douglas, J. L., Gustin, J. K., Viswanathan, K., Mansouri, M., Moses, A. V., and Fruh, K. (2010). The great escape: viral strategies to counter BST-2/tetherin. PLoS Pathog. 6,e1000913. doi:10.1371/journal.ppat.1000913
18. Douglas, J. L., Viswanathan, K., Mccarroll, M. N., Gustin, J. K., Fruh, K., and Moses, A. V. (2009). Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism. J. Virol. 83, 7931-7947.
19. Dube, M., Bego, M. G., Paquay, C., and Cohen, E. A. (2010a). Modulation of HIV-1-host interaction: role of the Vpu accessory protein. Retrovirology 7, 114.
20. Dube, M., Roy, B. B., Guiot-Guillain, P., Binette, J., Mercier, J., Chiasson, A., and Cohen, E. A. (2010b). Antagonism of tetherin restriction of HIV-1 release by Vpu involves binding and sequestration of the restriction factor in a perinuclear compartment. PLoS Pathog. 6,e1000856. doi:10.1371/journal.ppat.1000856
21. Eizirik, E., Murphy, W. J., and O'brien, S. J. (2001). Molecular dating and biogeography of the early placental mammal radiation. J. Hered. 92, 212-219.
22. Evans, D. T., Serra-Moreno, R., Singh, R. K., and Guatelli, J. C. (2010). BST-2/tetherin: a new component of the innate immune response to enveloped viruses. Trends Microbiol. 18,388-396.
23. Fukuma, A., Abe, M., Morikawa, Y., Miyazawa, T., and Yasuda, J. (2011). Cloning and characterization of the antiviral activity of feline Tetherin/BST-2. PLoS ONE 6, e18247. doi:10.1371/journal.pone.0018247
24. Gallo, R. C., Sarin, P. S., Gelmann, E. P., Robert-Guroff, M., Richardson, E., Kalyanaraman, V. S., Mann, D., Sidhu, G. D., Stahl, R. E., Zolla-Pazner, S., Leibowitch, J., and Popovic, M. (1983). Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS). Science 220,865-867.
25. Gao, F., Bailes, E., Robertson, D. L., Chen, Y., Rodenburg, C. M., Michael, S. F., Cummins, L. B., Arthur, L. O., Peeters, M., Shaw, G. M., Sharp, P. M., and Hahn, B. H. (1999). Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 397, 436-441.
26. Gifford, R. J. (2012). Viral evolution in deep time: lentiviruses and mammals. Trends Genet. 28, 89-100.
27. Gifford, R. J., Katzourakis, A., Tristem, M., Pybus, O. G., Winters, M., and Shafer, R. W. (2008). A transitional endogenous lentivirus from the genome of a basal primate and implications for lentivirus evolution. Proc. Natl. Acad. Sci. U.S.A. 105, 20362-20367
28. Gilbert, C., Maxfield, D. G., Goodman, S. M., and Feschotte, C. (2009). Parallel germline infiltration of a lentivirus in two Malagasy lemurs. PLoS Genet. 5, e1000425. doi:10.1371/journal.pgen.1000425
29. Gray, R. H., Wawer, M. J., Brookmeyer, R., Sewankambo, N. K., Serwadda, D., Wabwire-Mangen, F., Lutalo, T., Li, X., Vancott, T., and Quinn, T. C. (2001). Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 357, 1149-1153.
30. Gummuluru, S., Kinsey, C. M., and Emerman, M. (2000). An in vitro rapid-turnover assay for human immunodeficiency virus type 1 replication selects for cell-to-cell spread of virus. J. Virol. 74, 10882-10891.
31. Gupta, R. K., Mlcochova, P., Pelchen-Matthews, A., Petit, S. J., Mattiuzzo, G., Pillay, D., Takeuchi, Y., Marsh, M., and Towers, G. J. (2009). Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intra-cellular sequestration. Proc. Natl. Acad. Sci. U.S.A. 106,20889-20894.
32. Haque, M., Chen, J., Ueda, K., Mori, Y., Nakano, K., Hirata, Y., Kanamori, S., Uchiyama, Y., Inagi, R., Okuno, T., and Yamanishi, K. (2000). Identification and analysis of the K5 gene of Kaposi's sarcoma-associated herpesvirus. J. Virol. 74, 2867-2875.
33. Harris, R. S., and Liddament, M. T. (2004). Retroviral restriction by APOBEC proteins. Nat. Rev. Immunol. 4, 868-877.
34. Hauser, H., Lopez, L. A., Yang, S. J., Oldenburg, J. E., Exline, C. M., Guatelli, J. C., and Cannon, P. M. (2010). HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment. Retrovirology 7, 51.
35. Heeney, J. L., Dalgleish, A. G., and Weiss, R. A. (2006). Origins of HIV and the evolution of resistance to AIDS. Science 313, 462-466.
36. Homann, S., Smith, D., Little, S., Richman, D., and Guatelli, J. (2011). Upregulation of BST-2/tetherin by HIV infection in vivo. J. Virol. 85, 10659-10668.
37. Ishikawa, J., Kaisho, T., Tomizawa, H., Lee, B. O., Kobune, Y., Inazawa, J., Oritani, K., Itoh, M., Ochi, T., and Ishihara, K. (1995). Molecular cloning and chromosomal mapping of a bone marrow stromal cell surface gene, BST2, that maybe involved in pre-B-cell growth. Genomics 26, 527-534.
38. Izumi, T., Shirakawa, K., and Takaori-Kondo, A. (2008). Cytidine deaminases as a weapon against retro-viruses and a new target for antiviral therapy. Mini Rev. Med. Chem. 8, 231-238.
39. Jia, B., Serra-Moreno, R., Neidermyer, W., Rahmberg, A., Mackey, J., Fofana, I. B., Johnson, W. E., Westmoreland, S., and Evans, D. T. (2009). Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2. PLoS Pathog. 5, e1000429. doi:10.1371/journal.ppat. 1000429
40. Jolly, C., Booth, N. J., and Neil, S. J. (2010). Cell-cell spread of human immunodeficiency virus type 1 overcomes tetherin/BST-2-mediated restriction in T cells. J. Virol. 84, 12185-12199.
41. Jouvenet, N., Neil, S. J., Zhadina, M., Zang, T., Kratovac, Z., Lee, Y., Mcnatt, M., Hatziioannou, T., and Bieniasz, P. D. (2009). Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin. J. Virol. 83, 1837-1844.
42. Kaletsky, R. L., Francica, J. R., Agrawal-Gamse, C., and Bates, P. (2009). Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein. Proc. Natl. Acad. Sci. U.S.A. 106,2886-2891.
43. Kirchhoff, E (2010). Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses. Cell Host Microbe 8, 55-67.
44. Kitchen, L. W., Barin, F., Sullivan, J. L., Mclane, M. F., Brettler, D. B., Levine, P. H., and Essex, M. (1984). Aetiology of AIDS - antibodies to human T-cell leukaemia virus (type III) in haemophiliacs. Nature 312, 367-369.
45. Kobayashi, T., Ode, H., Yoshida, T., Sato, K., Gee, P., Yamamoto, S. P., Ebina, H., Strebel, K., Sato, H., and Koyanagi, Y (2011). Identification of amino acids in the human tetherin transmembrane domain responsible for HIV-1 Vpu interaction and susceptibility. J. Virol. 85, 932-945.
46. Krause, J., Fu, Q., Good, J. M., Viola, B., Shunkov, M. V., Derevianko, A. P., and Paabo, S. (2010). The complete mitochondrial DNA genome of an unknown hominin from southern Siberia. Nature 464, 894-897.
47. Kuhl, B. D., Sloan, R. D., Donahue, D. A., Bar-Magen, T., Liang, C., and Wainberg, M. A. (2010). Tetherin restricts direct cell-to-cell infection of HIV-1. Retrovirology 7, 115.
48. Kupzig, S., Korolchuk, V., Rollason, R., Sugden, A., Wilde, A., and Banting, G. (2003). Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology. Traffic 4, 694-709.
49. Le Tortorec, A., and Neil, S. J. (2009). Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virustype 2 envelope glycoprotein. J. Virol. 83,11966-11978.
50. Lim, E. S., and Emerman, M. (2009). Simian immunodeficiency virus SIVagm from African green monkeys does not antagonize endogenous levels of African green monkey tetherin/BST-2. J. Virol. 83, 11673-11681.
51. Lim, E. S., Malik, H. S., and Emerman, M. (2010). Ancient adaptive evolution of tetherin shaped the functions of Vpu and Nef in human immunodeficiency virus and primate lentiviruses. J. Virol. 84, 7124-7134.
52. Liu, J., Chen, K., Wang, J. H., and Zhang, C. (2010). Molecular evolution of the primate antiviral restriction factor tetherin. PLoS ONE 5, e1 1904. doi: 10.1371/journal.pone.00 11904
53. Lopez, L. A., Yang, S. J., Hauser, H., Exline, C. M., Haworth, K. G., Oldenburg, J., and Cannon, P. M. (2010). Ebola virus glycoprotein counteracts BST-2/Tetherin restriction in a sequence-independent manner that does not require tetherin surface removal. J. Virol. 84, 7243-7255.
54. Madani, N., and Kabat, D. (1998). An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein. J. Virol. 72, 10251-10255.
55. Mansouri, M., Viswanathan, K., Douglas, J. L., Hines, J., Gustin, J., Moses, A. V., and Fruh, K. (2009). Molecular mechanism of BST2/tetherin down-regulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus. J. Virol. 83,9672-9681.
56. Margottin, F., Bour, S. P., Durand, H., Selig, L., Benichou, S., Richard, V., Thomas, D., Strebel, K., and Benarous, R. (1998). Anovelhuman WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol Cell 1, 565-574.
57. Martin, N., and Sattentau, Q. (2009). Cell-to-cell HIV-1 spread and its implications for immune evasion. Curr. Opin. HIV AIDS 4, 143-149.
58. Martin-Serrano, J., and Neil, S. J. (2011). Host factors involved in retroviral budding and release. Nat. Rev. Microbiol. 9,519-531.
59. McNatt, M. W., Zang, T., Hatziioannou, T., Bartlett, M., Fofana, I. B., Johnson, W. E., Neil, S. J., and Bieniasz, P. D. (2009). Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants. PLoS Pathog. 5, e1000300. doi:10.1371/journal.ppat.1000300
60. Miyagi, E., Andrew, A. J., Kao, S., and Strebel, K. (2009). Vpu enhances HIV-1 virus release in the absence of Bst-2 cell surface down-modulation and intracellular depletion. Proc. Natl. Acad. Sci. U.S.A. 106, 2868-2873.
61. Neil, S. J., Sandrin, V., Sundquist, W. I., and Bieniasz, P. D. (2007). An interferon-alpha-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein. Cell Host Microbe 2, 193-203.
62. Neil, S. J., Zang, T., and Bieniasz, P. D. (2008). Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451, 425-430.
63. Pardieu, C., Vigan, R., Wilson, S. J., Calvi, A., Zang, T., Bieniasz, P., Kellam, P., Towers, G. J., and Neil, S. J. (2010). The RING-CH ligase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of tetherin. PLoS Pathog. 6, e1000843. doi:10.1371/journal.ppat. 1000843
64. Radoshitzky, S. R., Dong, L., Chi, X., Clester, J. C., Retterer, C., Spurgers, K., Kuhn, J. H., Sandwick, S., Ruthel, G., Kota, K., Boltz, D., Warren, T., Kranzusch, P. J., Whelan, S. P., and Bavari, S. (2010). Infectious Lassa virus, but not filoviruses, is restricted by BST-2/tetherin. J. Virol. 84, 10569-10580.
65. Reich, D., Green, R. E., Kircher, M., Krause, J., Patterson, N., Durand, E. Y., Viola, B., Briggs, A. W., Stenzel, U., Johnson, P. L., Maricic, T., Good, J. M., Marques-Bonet, T., Alkan, C., Fu, Q., Mallick, S., Li, H., Meyer, M., Eichler, E. E., Stoneking, M., Richards, M., Talamo, S., Shunkov, M. V., Derevianko, A. P., Hublin, J. J., Kelso, J., Slatkin, M., and Paabo, S. (2010). Genetic history of an archaic hominin group from Denisova Cave in Siberia. Nature 468, 1053-1060.
66. Rollason, R., Korolchuk, V., Hamilton, C., Jepson, M., and Banting, G. (2009). A CD317/tetherin-RICH2 complex plays a critical role in the organization of the subapical actin cytoskeleton in polarized epithelial cells.J. CellBiol. 184,721-736.
67. Rollason, R., Korolchuk, V., Hamilton, C., Schu, P., and Banting, G. (2007). Clathrin-mediated endocytosis of a lipid-raft-associated protein is mediated through a dual tyrosine motif. J. Cell Sci. 120, 3850-3858.
68. Russo, J. J., Bohenzky, R. A., Chien, M. C., Chen, J., Yan, M., Maddalena, D., Parry, J. P., Peruzzi, D., Edelman, I. S., Chang, Y., and Moore, P. S. (1996). Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl Acad. Sci. U.S.A. 93, 14862-14867.
69. Sato, K., Misawa, N., Fukuhara, M., Iwami, S., An, D. S., Ito, M., and Koyanagi, Y (in press). Vpu augments the initial burst phase of HIV-1 propagation and downregulates BST2 and CD4 in humanized mice. J. Virol. doi: 10.1128/JVI.07062-11
70. Sakuma, T., Noda, T., Urata, S., Kawaoka, Y., and Yasuda, J. (2009). Inhibition of Lassa and Marburg virus production by tetherin.J. Virol. 83,2382-2385.
71. Sato, K., Izumi, T., Misawa, N., Kobayashi, T., Yamashita, Y., Ohmichi, M., Ito, M., Takaori-Kondo, A., and Koyanagi, Y (2010). Remarkable lethal G-to-Amutations in vif-proficient HIV-1 provirus by individual APOBEC3 proteins in humanized mice. J. Virol. 84, 9546-9556.
72. Sato, K., Yamamoto, S. P., Misawa, N., Yoshida, T., Miyazawa, T., and Koyanagi, Y (2009). Comparative study on the effect of human BST-2/Tetherin on HIV-1 release in cells of various species. Retrovirology 6,53.
73. Sattentau, Q. (2008). Avoiding the void: cell-to-cell spread of human viruses. Nat. Rev. Microbiol. 6, 815-826.
74. Sauter, D., Hue, S., Petit, S. J., Plantier, J. C., Towers, G. J., Kirchhoff, F., and Gupta, R. K. (2011a). HIV-1 Group P is unable to antagonize human tetherin by Vpu, Env or Nef. Retrovirology 8,103.
75. Sauter, D., Vogl, M., and Kirchhoff, E (2011b). Ancient origin of a deletion in human BST2/Tetherin that confers protection against viral zoonoses. Hum. Mutat. 32, 1243-1245.
76. Sauter, D., Schindler, M., Specht, A., Landford, W N., Munch, J., Kim, K. A., Votteler, J., Schubert, U., Bibollet-Ruche, F., Keele, B. F., Takehisa, J., Ogando, Y., Ochsenbauer, C., Kappes, J. C., Ayouba, A., Peeters, M., Learn, G. H., Shaw, G., Sharp, P. M., Bieniasz, P., Hahn, B. H., Hatziioannou, T., and Kirchhoff, E (2009). Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains. Cell Host Microbe 6, 409-421.
77. Sawyer, S. L., Emerman, M., and Malik, H. S. (2004). Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G. PLoS Biol. 2, E275.doi:10.1371/journal.pbio.0020275
78. Schubert, U., Anton, L. C., Bacik, I., Cox, J. H., Bour, S., Bennink, J. R., Orlowski, M., Strebel, K., and Yewdell, J.W (1998). CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway. Virol. 72, 2280-2288.
79. Schubert, U., Bour, S., Ferrer-Montiel, A.V., Montal, M., Maldarell, F., and Strebel, K. (1996). The two bio logical activities of human immun odeficiency virus type 1 Vpu pro tein involve two separable structural domains. J. Virol. 70, 809-819.
80. Schubert, U., Bour, S., Willey, R. L., and Strebel, K. (1999). Regulation of virus release by the macrophage-tropic human immunodeficiency virus type 1 AD8 isolate is redundant and can be controlled by either Vpu or Env. J. Virol. 73, 887-896.
81. Schubert, U., Clouse, K. A., and Strebel, K. (1995). Augmentation of virus secretion by the human immunodeficiency virus type 1 Vpu protein is cell type independent and occurs in cultured human primary macrophages and lymphocytes. J. Virol. 69, 7699-7711.
82. Sharp, P.M., Shaw, G.M.,andHahn, B.H.(2005).Simian immunod-eficiency virus infection of chim-panzees. J. Virol. 79, 3891-3902.
83. Sheehy, A. M., Gaddis, N. C., Choi, J. D., and Malim, M. H. (2002). Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418, 646-650.
84. Simon, J.H., Gaddis, N.C., Fouchier, R.A., and Malim, M.H.(1998).Evidence for a newly discovered cellular anti-HIV-1phenotype. Nat.Med. 4, 1397-1400.
85. Skasko, M., Wang, Y., Tian, Y., Tokarev, A., Munguia, J., Ruiz, A., Stephens, E. B., Opella, S. J., and Guatelli, J. (2012). HIV-1 Vpu protein antagonizes innate restriction factor BST-2 via lipid-embedded helix-helix interactions. j. Biol Chem. 287, 58-67.
86. Theodore, T. S., Englund, G., Buckler-White, A., Buckler, C. E., Martin, M. A., and Peden, K. W (1996). Construction and characterization of a stable full-length macrophage-tropic HIV type 1 molecular clone that directs the production of high titers of progeny virions. AIDS Res. Hum. Retroviruses 12, 191-194.
87. Van Damme, N., Goff, D., Katsura, C., Jorgenson, R. L., Mitchell, R., Johnson, M. C., Stephens, E. B., and Guatelli, J. (2008). The interferon-induced protein BST-2 restricts HIV-1 release and is downregulatedfrom the cell surface by the viral Vpu protein. Cell Host Microbe 3, 245-252.
88. Varthakavi, V., Smith, R. M., Bour, S. P., Strebel, K., and Spearman, P. (2003). Viral protein U counteracts a human host cell restriction that inhibits HIV-1 particle production. Proc. Natl. Acad. Sci. U.S.A. 100, 15154-15159.
89. Vigan, R., and Neil, S. J. (2010). Determinants of tetherin antagonism in the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein. J. Virol. 84, 12958-12970.
90. Viswanathan, K., Smith, M. S., Malouli, D., Mansouri, M., Nelson, J. A., and Fruh, K. (2011). BST2/Tetherin enhances entry of human cytomegalovirus. PLoS Pathog. 7, e1002332. doi:10.1371/journal.ppat.1002332
91. Watanabe, R., Leser, G. P., and Lamb, R. A. (2011). Influenza virus is not restricted by tetherin whereas influenza VLP production is restricted byte therin. Virology 417,50-56.
92. Weidner, J. M., Jiang, D., Pan, X. B., Chang, J., Block, T. M., and Guo, J. T. (2010). Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms. J. Virol. 84, 12646-12657.
93. Wertheim, J. O., and Worobey, M. (2009). Dating the age of the SIV lineages that gave rise to HIV-1 and HIV-2. PLoS Comput. Biol. 5, e1000377. doi:10.1371/journal.pcbi. 1000377
94. Willey, R. L., Maldarelli, F., Martin, M. A., and Strebel, K. (1992). Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. J. Virol. 66, 7193-7200.
95. Worobey, M., Gemmel, M., Teuwen, D. E., Haselkorn, T., Kunstman, K., Bunce, M., Muyembe, J. J., Kabongo, J. M., Kalengayi, R. M., Van Marck, E., Gilbert, M. T., and Wolinsky, S. M. (2008). Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960. Nature 455, 661-664.
96. Worobey, M., Telfer, P., Souquiere, S., Hunter, M., Coleman, C.A., Metzger, M. J., Reed, P., Makuwa, M., Hearn, G., Honarvar, S., Roques, P., Apetrei, C., Kazanji, M., and Marx, P. A. (2010). Island biogeography reveals the deep history of SIV. Science 329, 1487.
97. Yang, S. J., Lopez, L. A., Exline, C. M., Haworth, K. G., and Cannon, P. M. (2011). Lack of adaptation to human tetherin in HIV-1 group O and P. Retrovirology 8, 78.
98. Yang, S. J., Lopez, L. A., Hauser, H., Exline, C. M., Haworth, K. G., and Cannon, P. M. (2010). Anti-tetherin activities in Vpu-expressing primate lentiviruses. Retrovirology 7, 13.
99. Yoder, A. D., Burns, M. M., Zehr, S., Delefosse, T., Veron, G., Goodman, S. M., and Flynn, J. J. (2003). Single origin of Malagasy Carnivora from an African ancestor. Nature 421,734-737.
100. Zhang, F., Wilson, S. J., Landford, W. C., Virgen, B., Gregory, D., Johnson, M. C., Munch, J., Kirchhoff, F., Bieniasz, P. D., and Hatziioannou, T. (2009). Nef proteins from simian immunodeficiency viruses are tetherin antagonists. Cell Host Microbe 6, 54-67.
101. Zhang, J., and Webb, D. M. (2004). Rapid evolution of primate antiviral enzyme APOBEC3G. Hum. Mol. Genet. 13,1785-1791.